BusinessKalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Fourth Quarter and Full Year Financial ResultsBy Nasdaq OMXJul 27, 2017, 8:01 PM UTC
BusinessKalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of MedicalBy Nasdaq OMXMar 9, 2017, 12:31 PM UTC
BusinessKalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of MedicalBy Nasdaq OMXMar 9, 2017, 12:31 PM UTC
BusinessKalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific OfficerBy Nasdaq OMXNov 29, 2016, 12:30 PM UTC
BusinessKalVista Pharmaceuticals Announces Closing of Merger with Carbylan TherapeuticsBy Nasdaq OMXNov 22, 2016, 12:30 PM UTC
